210 related articles for article (PubMed ID: 30360441)
1. The Importance of the Right Framework: Mitogen-Activated Protein Kinase Pathway and the Scaffolding Protein PTPIP51.
Dietel E; Brobeil A; Gattenlöhner S; Wimmer M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360441
[TBL] [Abstract][Full Text] [Related]
2. Orchestrating cellular signaling pathways-the cellular "conductor" protein tyrosine phosphatase interacting protein 51 (PTPIP51).
Brobeil A; Dietel E; Gattenlöhner S; Wimmer M
Cell Tissue Res; 2017 Jun; 368(3):411-423. PubMed ID: 27734150
[TBL] [Abstract][Full Text] [Related]
3. Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.
Dietel E; Brobeil A; Delventhal L; Tag C; Gattenlöhner S; Wimmer M
PLoS One; 2019; 14(5):e0216642. PubMed ID: 31075141
[TBL] [Abstract][Full Text] [Related]
4. The known interactome of PTPIP51 in HaCaT cells—inhibition of kinases and receptors.
Brobeil A; Koch P; Eiber M; Tag C; Wimmer M
Int J Biochem Cell Biol; 2014 Jan; 46():19-31. PubMed ID: 24501773
[TBL] [Abstract][Full Text] [Related]
5. PTPIP51 in protein interactions: regulation and in situ interacting partners.
Brobeil A; Bobrich M; Tag C; Wimmer M
Cell Biochem Biophys; 2012 Jul; 63(3):211-22. PubMed ID: 22544307
[TBL] [Abstract][Full Text] [Related]
6. PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia.
Brobeil A; Bobrich M; Graf M; Kruchten A; Blau W; Rummel M; Oeschger S; Steger K; Wimmer M
Leuk Res; 2011 Oct; 35(10):1367-75. PubMed ID: 21513978
[TBL] [Abstract][Full Text] [Related]
7. Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling.
Brobeil A; Chehab R; Dietel E; Gattenlöhner S; Wimmer M
Biomolecules; 2017 Jul; 7(3):. PubMed ID: 28754031
[TBL] [Abstract][Full Text] [Related]
8. PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ.
Petri MK; Koch P; Stenzinger A; Kuchelmeister K; Nestler U; Paradowska A; Steger K; Brobeil A; Viard M; Wimmer M
Histol Histopathol; 2011 Dec; 26(12):1531-43. PubMed ID: 21972092
[TBL] [Abstract][Full Text] [Related]
9. PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway.
Brobeil A; Kämmerer F; Tag C; Steger K; Gattenlöhner S; Wimmer M
Biomolecules; 2015 Apr; 5(2):485-504. PubMed ID: 25893721
[TBL] [Abstract][Full Text] [Related]
10. PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor.
Petri MK; Brobeil A; Planz J; Bräuninger A; Gattenlöhner S; Nestler U; Stenzinger A; Paradowska A; Wimmer M
J Neurooncol; 2015 May; 123(1):15-25. PubMed ID: 25862004
[TBL] [Abstract][Full Text] [Related]
11. PTPIP51 inhibits non-small-cell lung cancer by promoting PTEN-mediated EGFR degradation.
He M; Wang X; Chen W; Zhang J; Xiong Y; Cao L; Zhang L; Zhao N; Yang Y; Wang L
Life Sci; 2022 May; 297():120293. PubMed ID: 35240162
[TBL] [Abstract][Full Text] [Related]
12. PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway.
Yu C; Han W; Shi T; Lv B; He Q; Zhang Y; Li T; Zhang Y; Song Q; Wang L; Ma D
Cell Signal; 2008 Dec; 20(12):2208-20. PubMed ID: 18771726
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase interacting protein 51 (PTPIP51) mRNA expression and localization and its in vitro interacting partner protein tyrosine phosphatase 1B (PTP1B) in human placenta of the first, second, and third trimester.
Stenzinger A; Märker D; Koch P; Hoffmann J; Baal N; Steger K; Wimmer M
J Histochem Cytochem; 2009 Feb; 57(2):143-53. PubMed ID: 18854601
[TBL] [Abstract][Full Text] [Related]
14. Memory and PTPIP51--a new protein in hippocampus and cerebellum.
Brobeil A; Viard M; Petri MK; Steger K; Tag C; Wimmer M
Mol Cell Neurosci; 2015 Jan; 64():61-73. PubMed ID: 25496818
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells.
Dietel E; Brobeil A; Tag C; Gattenloehner S; Wimmer M
Oncogenesis; 2018 Aug; 7(8):64. PubMed ID: 30139932
[TBL] [Abstract][Full Text] [Related]
16. PTPIP51-a myeloid lineage specific protein interacts with PTP1B in neutrophil granulocytes.
Brobeil A; Graf M; Oeschger S; Steger K; Wimmer M
Blood Cells Mol Dis; 2010 Aug; 45(2):159-68. PubMed ID: 20627780
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase interacting protein 51--a jack-of-all-trades protein.
Brobeil A; Bobrich M; Wimmer M
Cell Tissue Res; 2011 May; 344(2):189-205. PubMed ID: 21369858
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
[TBL] [Abstract][Full Text] [Related]
19. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
20. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
